Low awareness of stroke guidelines and preference for Chinese herbs in community physicians: A national survey in China

Annals of Translational Medicine

Volumn 2, Issue 8, 2014, Pages

  Niu, Jing Wen ^a   Yuan, Jing ^a   Gao, Shan ^a   Xu, Wei Hai ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

China; Chinese traditional medicine; Community health workers; Guideline adherence; Stroke

Indexed keywords

EID: 85015489757     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2014.08.06     Document Type: Article

References (14)

1. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011;42:227-76.
2. Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e601S-36S.
3. Wang YJ, Zhang SM, Zhang L, et al. Chinese guidelines for the secondary prevention of ischemic stroke and transient ischemic attack 2010. CNS Neurosci Ther 2012;18:93-101.
4. Bryer A, Connor MD, Haug P, et al. The South African guideline for the management of ischemic stroke and transient ischemic attack: recommendations for a resource-constrained health care setting. Int J Stroke 2011;6:349-54.
5. Venketasubramanian N, Pwee KH, Chen CP. Singapore Ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke 2011;6:251-8.
6. Rothwell PM, Coull AJ, Giles MF, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004;363:1925-33.
7. Hong KS, Yegiaian S, Lee M, et al. Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation 2011;123:2111-9.
8. Mohan KM, Wolfe CD, Rudd AG, et al. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011;42:1489-94.
9. Wang Z, Li J, Wang C, et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry. PLoS One 2013;8:e56459.
10. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9.
11. Toso V, Carolei A, Gensini GF, et al. The Stroke in Italy and Related Impact on Outcome (SIRIO) study: design and baseline data. Neurol Sci 2006;27 Suppl 3:S263-7.
12. Leoo T, Lindgren A, Petersson J, et al. Risk factors and treatment at recurrent stroke onset: results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc Dis 2008;25:254-60.
13. Wu J, Jia LF, Jia JP. Awareness of secondary stroke prevention guidelines among neurologists in China: a cross-sectional online survey. Chin Med J (Engl) 2012;125:1867-70.
14. Wu B, Liu M, Liu H, et al. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 2007;38:1973-9.